Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.38 - $0.58 $2,432 - $3,711
-6,400 Reduced 0.73%
871,047 $339,000
Q2 2023

Aug 14, 2023

SELL
$0.39 - $0.94 $10.5 Million - $25.4 Million
-27,034,933 Reduced 96.86%
877,447 $394,000
Q1 2023

May 15, 2023

SELL
$0.79 - $1.91 $2.81 Million - $6.8 Million
-3,559,972 Reduced 11.31%
27,912,380 $22.9 Million
Q4 2022

Feb 14, 2023

BUY
$1.41 - $2.5 $7.68 Million - $13.6 Million
5,446,385 Added 20.93%
31,472,352 $49.1 Million
Q3 2022

Nov 15, 2022

SELL
$1.66 - $2.79 $10.2 Million - $17.2 Million
-6,169,707 Reduced 19.16%
26,025,967 $44.9 Million
Q2 2022

Aug 15, 2022

BUY
$1.44 - $3.98 $12.9 Million - $35.5 Million
8,927,746 Added 38.37%
32,195,674 $55.7 Million
Q1 2022

May 16, 2022

BUY
$2.97 - $5.2 $29.6 Million - $51.8 Million
9,967,498 Added 74.94%
23,267,928 $83.5 Million
Q4 2021

Feb 14, 2022

BUY
$4.99 - $7.46 $11.7 Million - $17.6 Million
2,353,164 Added 21.5%
13,300,430 $66.4 Million
Q3 2021

Nov 15, 2021

BUY
$7.16 - $9.69 $14.6 Million - $19.8 Million
2,040,108 Added 22.9%
10,947,266 $78.4 Million
Q2 2021

Aug 16, 2021

BUY
$6.23 - $10.03 $4.06 Million - $6.54 Million
651,621 Added 7.89%
8,907,158 $82.6 Million
Q1 2021

May 17, 2021

SELL
$8.81 - $16.96 $5.63 Million - $10.8 Million
-639,018 Reduced 7.18%
8,255,537 $76.6 Million
Q4 2020

Feb 16, 2021

BUY
$8.5 - $12.85 $7.59 Million - $11.5 Million
893,135 Added 11.16%
8,894,555 $78.7 Million
Q3 2020

Nov 10, 2020

BUY
$9.57 - $27.05 $8.93 Million - $25.2 Million
932,725 Added 13.2%
8,001,420 $92.8 Million
Q2 2020

Aug 14, 2020

BUY
$7.14 - $31.69 $38.1 Million - $169 Million
5,333,130 Added 307.28%
7,068,695 $191 Million
Q1 2020

May 11, 2020

BUY
$2.98 - $14.09 $5.17 Million - $24.5 Million
1,735,565 New
1,735,565 $12.9 Million

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $1.41B
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.